Share
3,759 Posts.
lightbulb Created with Sketch. 1286
clock Created with Sketch. 19/01/20
22:03
Share
Originally posted by stockrock:
↑
From a business standpoint, if approved, Ryoncil will be the lifeline that Mesoblast requires to fund its operations for the foreseeable future... with Mesoblast taking on debt, those interest repayments will be growing for some time yet, but there will be a genuine on-going revenue source that Mesoblast can depend on to service that debt. So the program is not only going to save many children's lives from 2020... it will literally save Mesoblast's corporate life.
Expand
One minor correction, remestemcel-L/Ryoncil continues to be available via the Expanded Access Program as I understand it, only the data collection for those 240 or so children followed up stopped. SI mentioned the continuation of the EAP in passing in one of webinars post P3 results, probably some time in the last half of 2019.
Last edited by
Treed :
19/01/20
This thread is closed.
You may not reply to this discussion at this time.
(20min delay)
